Relative Strength Chart Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.38 USD | -6.90% |
|
-32.48% | -1.91% |
| 07-31 | Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial | MT |
| 07-31 | Wedbush Adjusts Monte Rosa Therapeutics Price Target to $27 From $37, Maintains Outperform Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -6.90% | -32.48% | -1.91% | +221.09% | -40.09% | 1.4B |  |  |  |
- Stock Market
- Stocks
- GLUE Stock
- Charts Monte Rosa Therapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
